Autism spectrum disorders (ASD) are characterized by impairment in social interactions, communication deficits, and restricted repetitive interests and behaviors. There is evidence of both immune dysregulation and autoimmune phenomena in autism. We examined the regulatory cytokine transforming growth factor beta-1 (TGFβ1) because of its role in controlling immune responses. Plasma levels of active TGFβ1 were evaluated in 75 children with ASD compared with 68 controls. Children with ASD had significantly lower plasma TGFβ1 levels compared with typically developing controls (p = 0.0017) and compared with children with developmental disabilities other than ASD (p = 0.0037), after adjusting for age and gender. In addition, there were significant correlations between psychological measures and TGFβ1 levels, such that lower TGFβ1 levels were associated with lower adaptive behaviors and worse behavioral symptoms. The data suggest that immune responses in autism may be inappropriately regulated due to reductions in TGFβ1. Such immune dysregulation may predispose to the development of possible autoimmune responses and/or adverse neuroimmune interactions during critical windows in development.
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Introduction
Autism spectrum disorders (ASD) are complex neurodevelopmental disorders that are distinguished by qualitative impairments in social interaction, deficits in verbal and non-verbal communication, and restricted repetitive and stereotyped patterns of behavior and interests (Filipek et al., 2000; Lord et al., 2000) . There is growing evidence that an abnormal immune response may exert a negative influence on neurodevelopment, potentially contributing to the etiology of some cases of ASD. Alterations in appropriate regulation of the immune response may result in chronic inflammation, autoimmunity, or an inappropriate response to immune challenge in children with ASD (reviewed in Ashwood et al., 2006a) . Furthermore, abnormally regulated immune responses could potentially cause inflammation of the CNS or brain leading to altered neurodevelopment. Systemic immunologic aberrations in autism have often been associated with immune dysregulation, in particular, the generation of antibodies reactive against brain and CNS proteins (Ashwood et al., 2004; Cabanlit et al., 2007; Connolly et al., 1999; Connolly et al., 2006; Kozlovskaia et al., 2000; Singh et al., 1993; Singh et al., 1997a; Singh et al., 1997b; Singh et al., 2002; Singh and Rivas, 2004; Todd et al., 1988; Wills et al., 2007) . Indeed, autoantibodies to critical neuronal components have been reported in as many as 25-70% of individuals with autism (Connolly et al., 1999; Connolly et al., 2006; Singh et al., 2002; Singh and Rivas, 2004; Todd et al., 1988) . However, it must be noted that it is not currently known whether these antibodies are a cause of autism or generated as a result of inflammation in the brain and CNS. Many genetic studies have indicated a link between autism and genes that have immune functions, including complement C4 alleles, MHC haplotypes B44-SC30-DR4, human leukocyte antigen (HLA)-DRB1, and DR13 (Ferrante et al., 2003; Torres et al., 2001; Warren et al., 1991; Warren et al., 1996) . Moreover, several studies have shown immune abnormalities in patients with autism including abnormal or skewed T helper cell cytokine profiles, decreased
